Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes

PloS One
Daiki HiranoKazuaki Chayama

Abstract

Serrated adenocarcinoma (SAC) is considered the end stage of the serrated neoplasia pathway. Although SAC prognosis is not widely recognized, the serrated pathway-associated subtype consistently exhibits unfavorable prognosis in genetic studies. Herein, we classified molecularly distinct subtypes of serrated adenocarcinomas and clarified their associated clinicopathological characteristics and genetic changes. We examined 38 early-stage colorectal SACs. Of these, 24 were classified into three molecularly distinct groups by colon cancer subtyping (CCS). The clinicopathological characteristics, Ki 67 labeling index (LI), and SAC epithelial serration were assessed. The DNA from carcinomas and normal tissue/adenoma was extracted by laser microdissection and sequenced by next-generation sequencing, and mutation numbers and patterns of a 15-oncogene panel were determined. The CCS groups included CCS1 (CDX2+, HTR2B-, FRMD6-, ZEB1-, and microsatellite instable-low [MSI-L]/microsatellite stable [MSS]; 14 cases), CCS2 (microsatellite instable-high [MSI-H], 5 cases), and CCS3 (CDX2-, HTR2B+, FRMD6+, ZEB1+, and MSI-L/MSS; 5 cases). Invasive cancer was significantly more frequent in CCS3 than in CCS1 (5/5 versus 3/14, respectively). Ki67 LI...Continue Reading

References

Sep 1, 1988·The New England Journal of Medicine·B VogelsteinJ L Bos
Oct 21, 2000·Gastroenterology·D G SilbergP G Traber
May 12, 2004·Cancer Biology & Therapy·Rong-Jun GuoJohn P Lynch
Jun 19, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Vassil KaimaktchievChristopher L Corless
Dec 2, 2004·Nature Reviews. Cancer·Judith S Sebolt-Leopold, Roman Herrera
Jul 1, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alessandro LugliLuigi Maria Terracciano
Apr 24, 2009·Developmental Cell·Nan GaoKlaus H Kaestner
Jul 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yoshifumi BabaShuji Ogino
Nov 3, 2009·Gastrointestinal Endoscopy·René LambertGeorge Triadafilopoulos
Nov 13, 2009·International Journal of Cancer. Journal International Du Cancer·Inti ZlobecAlessandro Lugli
Feb 10, 2010·Nature Reviews. Clinical Oncology·Eduardo Vilar, Stephen B Gruber
Apr 28, 2010·Gastroenterology·Maria S Pino, Daniel C Chung
Apr 28, 2010·Gastroenterology·Barbara Leggett, Vicki Whitehall
Dec 17, 2010·World Journal of Gastrointestinal Oncology·Alberto MoránManuel Benito
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Apr 5, 2011·Histopathology·Karoliina StefaniusMarkus J Mäkinen
Mar 22, 2012·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Yosuke ShidaJohji Imura
Feb 11, 2015·World Journal of Gastroenterology : WJG·Jeong Mo BaeGyeong Hoon Kang
Oct 13, 2015·Nature Medicine·Justin GuinneySabine Tejpar
Jan 21, 2016·The New England Journal of Medicine·Piero DalerbaMichael F Clarke
Mar 23, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C PilatiP Laurent-Puig
Jun 9, 2017·Nature Communications·Moiez AliKris C Wood
Dec 14, 2017·BMC Gastroenterology·Daiki HiranoKazuaki Chayama

❮ Previous
Next ❯

Citations

Aug 11, 2020·Surgical Pathology Clinics·Melanie Johncilla, Rhonda K Yantiss

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
PCR
light microscopy
electrophoresis

Software Mentioned

Qubit HS
R
BaseSpace
Agilent 2100 Expert

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.